Study highlights monoclonal antibody therapy as safe and effective in preventing rabies

Rabies is one of the deadliest infectious diseases, but it is also preventable when treated quickly after an animal bite. A new post-licensure clinical study published in The Lancet further demonstrates that Rabishield, a monoclonal antibody therapy developed by UMass Chan Medical School in partnership with the Serum Institute of India, offers a safe and effective alternative to older rabies treatments.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup